Journal article
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
- Abstract:
-
OBJECTIVES: We sought to assess the ability of N-terminal pro-B-type natriuretic peptide (N-BNP) to predict vascular events in high-risk people and to test whether statins benefit people with high levels of N-BNP.
BACKGROUND: The predictive value of N-BNP for occlusive vascular events and the effects of statins in people with high N-BNP levels are uncertain.
METHODS: A total of 20,536 people were assigned randomly to simvasta...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Medical Research Council
More from this funder
British Heart Foundation
More from this funder
Merck and Co.
More from this funder
Roche Vitamins Ltd.
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Journal of the American College of Cardiology Journal website
- Volume:
- 49
- Issue:
- 3
- Pages:
- 311-319
- Publication date:
- 2007-01-01
- DOI:
- EISSN:
-
1558-3597
- ISSN:
-
0735-1097
- Source identifiers:
-
33731
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:33731
- UUID:
-
uuid:36f306e8-24e3-4853-b17a-1a3082a28236
- Local pid:
- pubs:33731
- Deposit date:
- 2013-02-20
Terms of use
- Copyright holder:
- Elsevier BV
- Copyright date:
- 2007
- Notes:
- Copyright 2007 the American College of Cardiology Foundation. Published by Elsevier B.V. All rights reserved. Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://www.elsevier.com/open-access/userlicense/1.0/
- Licence:
- Other
If you are the owner of this record, you can report an update to it here: Report update to this record